Cart
sales@molnova.com
PZ-2891
CAS No. 2170608-82-7
PZ-2891( —— )
Catalog No. M20770 CAS No. 2170608-82-7
PZ-2891 is an orally bioavailable brain penetrant pantothenate kinase (PANK) modulator(hPANK3IC50:1.3 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 200 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | 494 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePZ-2891
-
NoteResearch use only, not for human use.
-
Brief DescriptionPZ-2891 is an orally bioavailable brain penetrant pantothenate kinase (PANK) modulator(hPANK3IC50:1.3 nM).
-
DescriptionPZ-2891 is an orally bioavailable brain penetrant pantothenate kinase (PANK) modulator(hPANK3IC50:1.3 nM).
-
In VitroPZ-2891 inhibits mouse pantothenate kinases PANK1β, PANK2, and PANK3 with IC50s of48.7±5.1 nM, 1.0±0.1 nM, and 1.9±0.2 nM, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorpantothenate kinase (PANK)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2170608-82-7
-
Formula Weight349.43
-
Molecular FormulaC20H23N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:75 mg/mL (214.64 mM)
-
SMILESCC(C)c1ccc(CC(=O)N2CCN(c3ccc(C#N)nn3)CC2)cc1
-
Chemical Name6-(4-(2-(4-isopropylphenyl)acetyl)piperazin-1-yl)pyridazine-3-carbonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lalit Kumar Sharma et al. A therapeutic approach to pantothenate kinase associated neurodegeneration.[J]. Nature communications 2018.
molnova catalog
related products
-
Aristolone
Aristolone has potential anti-cancer activity.
-
L-655708
L-655708 is a selective and highly potent GABAA receptor reverse agonist with a Ki value of 0.45 nM.
-
BAM 15
BAM 15 is an uncoupler of mitochondrial protonophore. BAM 15 is fully capable of increasing mitochondrial respiration in the presence of oligomycin and does so across a broader concentration range than FCCP in both myoblasts and hepatocytes and it is able to increase O2 consumption across a broad dosing range without increasing ROS.
